Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study
- 31 July 1992
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 95 (1), 1-13
- https://doi.org/10.1016/0021-9150(92)90170-l
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Cholesterol flux in cholesterol ester-loaded macrophages in an in vitro perfusion systemAtherosclerosis, 1991
- Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-upJAMA, 1990
- Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimensJAMA, 1990
- Factors linking cholesterol to atherosclerotic plaquesThe American Journal of Cardiology, 1988
- Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass graftsJAMA, 1987
- Plasma exchange and low density lipoprotein apheresis in Watanabe heritable hyperlipidemic rabbits.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1987
- Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)JAMA, 1986
- Specific sorbent of apolipoprotein B-containing lipoproteins for plasmapheresis. Characterization and experimental use in hypercholesterolemic rabbits.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol loweringJAMA, 1984
- PLASMA EXCHANGE IN THE MANAGEMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLÆMIAThe Lancet, 1975